✦ LIBER ✦

Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial

✍ Scribed by Péter Halász; Reetta Kälviäinen; Maria Mazurkiewicz-Beldzińska; Felix Rosenow; Pamela Doty; David Hebert; Timothy Sullivan; on behalf of the SP755 Study Group

Book ID: 109111106
Publisher: Wiley (Blackwell Publishing)
Year: 2009
Tongue: English
Weight: 494 KB
Volume: 50
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1167.2008.01951.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lacosamide as adjunctive therapy for par

Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial

✍ Steve Chung; Michael R. Sperling; Victor Biton; Gregory Krauss; David Hebert; G. 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 439 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures

✍ Jonathan J. Halford; Elinor Ben-Menachem; Patrick Kwan; Seth Ness; Jennifer Schm 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 459 KB

Rufinamide for the adjunctive treatment

Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial

✍ Martin J. Brodie; William E. Rosenfeld; Blanca Vazquez; Rajesh Sachdeo; Carlos P 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 636 KB

Efficacy and safety of eslicarbazepine a

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study

✍ Christian Elger; Peter Halász; Joana Maia; Luis Almeida; Patrício Soares-da-Silv 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 337 KB

A randomized controlled trial evaluating

A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results

✍ Andreas A. Argyriou; Elisabeth Chroni; Angelos Koutras; Gregoris Iconomou; Spiri 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 140 KB

Efficacy and safety of topical WBI-1001

Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial

✍ R. Bissonnette; Y. Poulin; Y. Zhou; J. Tan; H.C. Hong; J. Webster; W. Ip; L. Tan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB